Your browser doesn't support javascript.
loading
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Richardson, Paul G; Riches, Marcie L; Kernan, Nancy A; Brochstein, Joel A; Mineishi, Shin; Termuhlen, Amanda M; Arai, Sally; Grupp, Stephan A; Guinan, Eva C; Martin, Paul L; Steinbach, Gideon; Krishnan, Amrita; Nemecek, Eneida R; Giralt, Sergio; Rodriguez, Tulio; Duerst, Reggie; Doyle, John; Antin, Joseph H; Smith, Angela; Lehmann, Leslie; Champlin, Richard; Gillio, Alfred; Bajwa, Rajinder; D'Agostino, Ralph B; Massaro, Joseph; Warren, Diane; Miloslavsky, Maja; Hume, Robin L; Iacobelli, Massimo; Nejadnik, Bijan; Hannah, Alison L; Soiffer, Robert J.
Afiliação
  • Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
  • Riches ML; Division of Hematology/Oncology, University of North Carolina Hospitals, Bone Marrow and Stem Cell Transplant Clinic, University of North Carolina Cancer Hospital, Chapel Hill, NC;
  • Kernan NA; Pediatric Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY;
  • Brochstein JA; Department of Pediatrics, Stem Cell Transplant Program, Cohen Children's Medical Center, New Hyde Park, NY;
  • Mineishi S; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL;
  • Termuhlen AM; Division of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Children's Hospital Los Angeles, Los Angeles, CA;
  • Arai S; Blood and Marrow Transplantation, Stanford University Medical Center, Stanford, CA;
  • Grupp SA; Pediatric Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA;
  • Guinan EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Hematology/Oncology, Children's Hospital, Boston, MA;
  • Martin PL; Division of Pediatric Blood and Marrow Transplant, Duke University Medical Center, Durham, NC;
  • Steinbach G; Gastroenterology Division, University of Washington School of Medicine and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
  • Krishnan A; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA;
  • Nemecek ER; Pediatric Bone Marrow Transplant Program, Oregon Health and Science University, Portland, OR;
  • Giralt S; Adult Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY;
  • Rodriguez T; Hematology/Oncology, Loyola University Medical Center, Chicago, IL;
  • Duerst R; Stem Cell Transplant Program, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL;
  • Doyle J; Pediatric Hematology/Oncology, CancerCare Manitoba and the University of Manitoba, Winnipeg, Manitoba, Canada;
  • Antin JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
  • Smith A; Division of Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN;
  • Lehmann L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Hematology/Oncology, Children's Hospital, Boston, MA;
  • Champlin R; Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, The University of Texas, Houston, TX;
  • Gillio A; Department of Pediatrics, Hackensack University Medical Center, Hackensack, NJ;
  • Bajwa R; Department of Hematology/Oncology/BMT, The Ohio State University/Nationwide Children's Hospital, Columbus, OH;
  • D'Agostino RB; Department of Mathematics and Statistics, Boston University, Boston, MA;
  • Massaro J; Department of Mathematics and Statistics, Boston University, Boston, MA;
  • Warren D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
  • Miloslavsky M; Biostatistics, Jazz Pharmaceuticals, Palo Alto, CA;
  • Hume RL; Regulatory Affairs, Jazz Pharmaceuticals, Palo Alto, CA;
  • Iacobelli M; Life Sciences, Techitra Srl, Milano, Italy;
  • Nejadnik B; Research and Clinical Development, Galena Biopharma, San Ramon, CA; and.
  • Hannah AL; Clinical Operations, Jazz Pharmaceuticals, Palo Alto, CA.
  • Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;
Blood ; 127(13): 1656-65, 2016 Mar 31.
Article em En | MEDLINE | ID: mdl-26825712
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polidesoxirribonucleotídeos / Hepatopatia Veno-Oclusiva / Fibrinolíticos / Insuficiência de Múltiplos Órgãos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polidesoxirribonucleotídeos / Hepatopatia Veno-Oclusiva / Fibrinolíticos / Insuficiência de Múltiplos Órgãos Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2016 Tipo de documento: Article